+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oral zolmitriptan is effective in the acute treatment of cluster headache



Oral zolmitriptan is effective in the acute treatment of cluster headache



Neurology 54(9): 1832-1839



Objective: To evaluate the efficacy and tolerability of oral zolmitriptan 5 mg and 10 mg and placebo in cluster headache. Methods: A multicenter, double-blind, randomized, three-period, crossover, outpatient study. Adult patients received placebo and zolmitriptan 5 mg and 10 mg orally for the acute treatment of episodic or chronic cluster headache. Headache intensity was rated by a five-point scale: none, mild, moderate, severe, or very severe. Patients only treated moderate to very severe headaches. The primary efficacy measure was headache response (two-point or greater reduction from baseline in the cluster headache rating scale) at 30 minutes. Secondary efficacy measures included proportion of patients with initial headache relief within 15 and 30 minutes, mild or no pain at 30 minutes, meaningful headache relief, and use of escape medication. Results: A total of 124 patients took at least one dose of study medication, with 73% having episodic and 27% chronic cluster headache. For the primary endpoint, there was a treatment-by-cluster-headache-type interaction (p = 0.0453). Therefore, results are presented separately for chronic and episodic cluster headache. In patients with episodic cluster headache, the difference between zolmitriptan 10 mg and placebo at 30 minutes reached significance (47% versus 29%; p = 0.02). Mild or no pain at 30 minutes was reported by 60%, 57%, and 42% patients treated with zolmitriptan 10 mg, zolmitriptan 5 mg, and placebo (both p ltoreq 0.01 versus placebo). For all other secondary endpoints, zolmitriptan 10 mg was significantly superior to placebo in episodic cluster headache patients, whereas zolmitriptan 5 mg was significantly superior to placebo for three of the four secondary endpoints. In patients with chronic cluster headache, response rates following zolmitriptan 5 mg or 10 mg were not significantly different from placebo at any endpoint. Zolmitriptan 5 mg and 10 mg were well tolerated. Conclusion: Oral zolmitriptan is efficacious in episodic cluster headache.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011096969

Download citation: RISBibTeXText

PMID: 11071515


Related references

Oral zolmitriptan is effective in the acute treatment of episodic cluster headache. Neurology 52(6 Suppl. 2): A257-A258, 1999

Is oral zolmitriptan efficacious in the acute treatment of cluster headache?. Journal of Family Practice 49(9): 784, 849, 2000

Effectiveness of zolmitriptan nasal spray for the acute treatment of cluster headache: study 2. Current Neurology and Neuroscience Reports 8(2): 86, 2008

Effectiveness of zolmitriptan nasal spray for the acute treatment of cluster headache: study 1. Current Neurology and Neuroscience Reports 8(2): 85-86, 2008

Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 49(9): 1315-1323, 2010

Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 69(9): 821-826, 2007

Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache. Current Medical Research and Opinion 15(4): 282-289, 2000

Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Archives of Neurology 63(11): 1537-1542, 2006

Subcutaneous octreotide is effective in the treatment of acute cluster headache A double-blind placebo-controlled crossover Study. Cephalalgia 23(7): 580, 2003

Experience with intranasal zolmitriptan in cluster headache. Neurologia 21(3): 131-134, 2006

Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil. Bmc Neurology 13: 99, 2013

Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 22(2): 101-106, 2002

Treatment of acute cluster headache with sumatriptan. The Sumatriptan Cluster Headache Study Group. New England Journal of Medicine 325(5): 322-326, 1991

Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurologica Scandinavica 88(1): 63-69, 1993